<DOC>
	<DOCNO>NCT01548001</DOCNO>
	<brief_summary>This study intend evaluate efficacy safety Iguratimod alone Iguratimod combination Methotrexate ( MTX ) versus Methotrexate alone patient Rheumatoid Arthritis ( RA ) .</brief_summary>
	<brief_title>Long-term Efficacy Iguratimod Alone Iguratimod Combination With Methotrexate Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Subjects diagnosis RA accord diagnostic criterion American College Rheumatology ( ACR ) ( revised 1987 ) Rheumatoid Arthritis 3 month 2 year time initial diagnosis Subjects active RA time screen Subjects naive MTX RA relate biologics Written inform consent Preceding treatment DMARDs , immunosuppressant ( cyclophosphamide , cyclosporine , azathioprine , etc . ) , Tripterygium within 4 week prior study entry Chest xray abnormality , tuberculosis , interstitial pulmonary fibrosis , etc . ALT &gt; 1.5×ULN , AST &gt; 1.5×ULN , Cr &gt; 135umol/L WBC &lt; 4×109/L，HGB &lt; 85g/L，PLT &lt; 100×109/L Subjects serious cardiovascular , renal , hematologic endocrine disease Pregnant lactate woman Allergic study drug History alcoholism Subjects mental illness Subjects receive live vaccine recently Subjects participate clinical study within 3 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Iguratimod</keyword>
	<keyword>Methotrexate</keyword>
</DOC>